Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.680
+0.006 (0.88%)
Apr 29, 2026, 9:44 AM EDT - Market open

Pasithea Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Net Income
-20.43-13.9-15.96-13.94-2.17
Upgrade
Depreciation & Amortization
0.660.650.650.010
Upgrade
Loss (Gain) From Sale of Assets
0.1--0.07--
Upgrade
Asset Writedown & Restructuring Costs
4.16----
Upgrade
Stock-Based Compensation
0.30.770.590.841.22
Upgrade
Other Operating Activities
0.310.080.40.36-2.33
Upgrade
Change in Accounts Payable
0.01-1.431.070.750.44
Upgrade
Change in Other Net Operating Assets
-0.33-0.090.50.1-0.33
Upgrade
Operating Cash Flow
-15.21-13.92-13.43-13.69-3.17
Upgrade
Capital Expenditures
---0.03-0.11-0.02
Upgrade
Sale of Property, Plant & Equipment
0.01-0.11--
Upgrade
Cash Acquisitions
----2.19-
Upgrade
Other Investing Activities
--0.32-0.63-
Upgrade
Investing Cash Flow
0.01-0.4-2.93-0.02
Upgrade
Short-Term Debt Issued
--0.39--
Upgrade
Total Debt Issued
--0.39--
Upgrade
Short-Term Debt Repaid
---0.39--
Upgrade
Total Debt Repaid
---0.39--
Upgrade
Issuance of Common Stock
63.970--57.24
Upgrade
Repurchase of Common Stock
---3.73--
Upgrade
Other Financing Activities
-0.454.52--3.21-1.31
Upgrade
Financing Cash Flow
63.524.52-3.73-3.2155.93
Upgrade
Foreign Exchange Rate Adjustments
0.02-0-00.01-0.01
Upgrade
Miscellaneous Cash Flow Adjustments
---0-
Upgrade
Net Cash Flow
48.34-9.41-16.76-19.8152.72
Upgrade
Free Cash Flow
-15.21-13.92-13.46-13.8-3.2
Upgrade
Free Cash Flow Margin
-----21216.05%
Upgrade
Free Cash Flow Per Share
-2.16-12.70-10.97-10.93-6.14
Upgrade
Cash Interest Paid
0.01----
Upgrade
Levered Free Cash Flow
-6.47-9-7.32-6.52-1.51
Upgrade
Unlevered Free Cash Flow
-6.47-9-7.32-6.52-1.5
Upgrade
Change in Working Capital
-0.32-1.521.570.850.11
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.